Introduction {#s1}
============

Hyperlipidemia is well recognized as a risk factor for cardiovascular disease (CVD). As diet represents the most important determinant of hyperlipidemia, dietary animal models can be useful for the study of CVD progression [@pone.0037581-Lissner1]. High-fat, high-cholesterol, and high-sugar diets have been shown to induce hyperlipidemia, obesity, and insulin resistance in humans and rodents [@pone.0037581-Radonjic1]--[@pone.0037581-OronHerman1]. Dietary-induced hyperlipidemia pig models have also been established [@pone.0037581-Kobari1]--[@pone.0037581-Zhang1].

Compared to rodents, pigs are a useful animal model for elucidating the molecular mechanisms underlying the transition from a healthy state to the progression of diseases caused by hyperlipidemia because they are able to breed stably over a long period, and have a similar anatomy and digestive physiology to humans [@pone.0037581-Lunney1], [@pone.0037581-Simon1]. In addition, miniature pigs are easier to breed and to handle than other non-primates are, making them a convenient species for preclinical tests [@pone.0037581-Vodicka1]. In September 2003, the Swine Genome Sequencing Consortium (SGSC) was formed to promote pig genome sequencing under international coordination [@pone.0037581-Schook1]. The swine research environment has been enhanced since members of the SGSC announced a completed swine genome map in November 2009 [@pone.0037581-Archibald1].

To evaluate temporal changes in gene expression profiles with the progression of dietary-induced alterations, minimally invasive blood sampling, which allows for the direct measurement of immune-responsive blood cells, excels over other invasive biopsy techniques for disease diagnostics and assessment of drug responses, as well as health monitoring. If biomarker candidate genes can be identified from blood analyses, these may be useful for diagnosis in humans. Use of whole blood is preferable to other specimens on two accounts. Firstly, RNA expression and degradation are susceptible to artificial manipulations such as cell separation and extraction. Whole blood manipulation can reduce these risks via the use of RNA blood collection tubes. Secondly, whole blood is an attractive prime tissue due to its critical role in immune responses, metabolism, and communication with cells and the extracellular matrix in almost all body tissues and organs. Whole blood will depart from the normal state when a considerable alteration occurs in some blood cell subpopulations, tissues, or organs. Moreover, blood samples can be obtained repeatedly from miniature pigs, and blood RNA contains an enormous amount of information on the expression of messenger RNA and non-coding functional RNA molecules that are not translated into proteins. Thus, analysis of blood RNA provides an opportunity to detect subtle changes in physiological state. We consider it particularly important to identify gene expression characteristics in whole blood. Microarray techniques allow the detection of genome-wide perturbations in response to different treatments and the measurement of various responses using a multitude of gene probes. Toxicogenomics, in which microarray techniques are specifically used in toxicology tests, has been widely recognized as one of the standard safety procedures for chemicals [@pone.0037581-WilliamsDevane1]--[@pone.0037581-Tong1]. Gene expression microarrays have been used particularly for the screening of genes involved in specific biological processes of interest. Microarrays also allow the clustering of genes according to similar patterns of expression or functions. In this study, we conducted a series of whole blood microarray experiments to evaluate long-term alterations during 27-week feeding periods using specific pathogen-free (SPF) miniature pigs.

There are two main types of dietary protocols for hyperlipidemia pig models, one with cholesterol and animal lipids [@pone.0037581-Kobari1]--[@pone.0037581-Bowles1], and the other with cholesterol, animal lipids, and sucrose [@pone.0037581-Yin1], [@pone.0037581-Zhang1]. Some studies have focused primarily on a subset of genes, but this approach cannot elucidate whole blood RNA profiles during the process of change. We selected two typical dietary protocols. One was a high-fat and high-cholesterol diet (HFCD) containing 15% lard and 2% cholesterol; the other was a high-fat, high-cholesterol, and high-sucrose diet (HFCSD) containing 15% lard, 2% cholesterol, and 37% sucrose. The present microarray analyses of whole blood were conducted according to the following aspects. The first analysis dealt with similarity among individuals based on the correlation coefficient. Variation among individuals of the same dietary group and between the different dietary periods was examined. The second analysis addressed the function of genes. Up- or down-regulated genes for each dietary protocol were examined by functional categorization. While whole blood RNA derives from white blood cell RNA, whole blood gene expression profiles may not entirely correspond to those of white blood cells [@pone.0037581-Min1]. White blood cell microarray analyses conducted at the end of each dietary period are greatly influenced by diet, and the variations between the expression profiles of white blood cells and whole blood were assessed for each dietary group.

Results {#s2}
=======

Characteristics of study subjects {#s2a}
---------------------------------

Temporal changes in mean body weights for the 3 dietary groups are shown in [Figure 1](#pone-0037581-g001){ref-type="fig"}. One-way ANOVA analysis for dietary-related variation revealed no significant difference at any feeding period except at week 12. In this study, the term "week" refers to the dietary period and not to the period since birth, unless otherwise stated. [Table 1](#pone-0037581-t001){ref-type="table"} lists the fasting plasma triglyceride concentrations for the group fed the high-fat, high-cholesterol diet (HFCD) and the group fed the high-fat, high-cholesterol, and high-sucrose diet (HFCSD). Almost no changes were observed in fasting plasma triglyceride levels. Fasting plasma total cholesterol concentrations had increased in the HFCD group and the HFCSD group by week 5 of the feeding period (P\<0.001) and were maintained between 350 and 1150 mg/dL from weeks 10--27 ([Table 2](#pone-0037581-t002){ref-type="table"}). Fasting plasma high-density lipoprotein cholesterol (HDL-C) concentrations increased and showed significant differences (P\<0.001) from weeks 10--27 between two dietary treatment groups and control ([Table 3](#pone-0037581-t003){ref-type="table"}). Fasting plasma low-density lipoprotein cholesterol (LDL-C) concentrations also increased and showed significant differences from weeks 5--27 between two dietary treatment groups and control ([Table 4](#pone-0037581-t004){ref-type="table"}). Fasting plasma glucose concentrations remained unchanged ([Table 5](#pone-0037581-t005){ref-type="table"}). The number of white blood cells and the ratios of granulocytes (basophiles, eosinophils, neutrophils, lymphocytes, and monocytes) to white blood cells were not statistically significant among the three test groups ([Table 6](#pone-0037581-t006){ref-type="table"}--[](#pone-0037581-t007){ref-type="table"} [](#pone-0037581-t008){ref-type="table"} [](#pone-0037581-t009){ref-type="table"} [](#pone-0037581-t010){ref-type="table"} [11](#pone-0037581-t011){ref-type="table"}). The liver (P\<0.001) and spleen (P\<0.01) weights were increased significantly compared to the controls in both the HFCD and HFCSD groups. In contrast, the heart, kidney, and stomach weights remained unchanged ([Table 12](#pone-0037581-t012){ref-type="table"}).

![Subject body weights.\
**•** represents control, **⧫** represents HFCD, and ▴ represents HFCSD. Values correspond to means (SD).](pone.0037581.g001){#pone-0037581-g001}

10.1371/journal.pone.0037581.t001

###### Fasting plasma triglyceride levels (mg/dL).

![](pone.0037581.t001){#pone-0037581-t001-1}

  Time point (weeks)     Control      HFCD        HFCSD     *P* [†](#nt102){ref-type="table-fn"}
  -------------------- ----------- ----------- ----------- --------------------------------------
  0                     44.5±16.9   42.4±14.4   37.8±21.4                    NS
  5                     25.3±7.2    22.0±22.0   19.5±9.3                     NS
  10                    21.0±2.3    30.4±18.9   30.2±14.7                    NS
  14                    10.8±5.6     7.4±5.0     6.0±3.2                     NS
  19                    10.2±3.6    14.2±14.0   15.6±7.2                     NS
  23                    16.8±7.6     8.2±3.6     8.6±3.2                   \<.05
  27                     8.0±2.3     7.2±3.4    12.0±13.5                    NS

Values are mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t002

###### Fasting plasma total cholesterol levels (mg/dL).

![](pone.0037581.t002){#pone-0037581-t002-2}

  Time point (weeks)     Control       HFCD          HFCSD      *P* [†](#nt104){ref-type="table-fn"}
  -------------------- ----------- ------------- ------------- --------------------------------------
  0                     99.0±21.3   117.4±22.2    100.4±22.5                     NS
  5                     103.8±4.8   620.0±292.6   605.0±131.2                  \<.001
  10                    81.2±11.1   780.0±239.3   619.0±205.3                  \<.001
  14                    54.4±12.4   646.7±141.4   480.3±43.3                   \<.001
  19                    54.6±11.9   745.4±172.7   874.6±208.4                  \<.001
  23                    54.2±16.9   562.6±144.9   654.4±219.2                  \<.001
  27                    53.0±8.8    541.4±148.5   689.4±267.3                  \<.001

Values are mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t003

###### Fasting plasma HDL cholesterol levels (mg/dL).

![](pone.0037581.t003){#pone-0037581-t003-3}

  Time point (weeks)     Control       HFCD        HFCSD      *P* [†](#nt106){ref-type="table-fn"}
  -------------------- ----------- ------------ ------------ --------------------------------------
  0                     39.3±11.8   50.3±14.8    41.9±11.5                     NS
  5                     50.3±3.1     81.1±6.3    70.7±19.8                     NS
  10                    41.1±5.9    105.2±30.2   96.2±19.6                   \<.001
  14                    36.2±5.4    99.3±21.4    106.3±14.9                  \<.001
  19                    30.6±7.6    100.3±22.7   117.9±19.8                  \<.001
  23                    31.4±8.7    122.3±8.2    110.7±14.2                  \<.001
  27                    29.1±4.5    119.2±12.1   106.6±14.6                  \<.001

Values are mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t004

###### Fasting plasma LDL cholesterol levels (mg/dL).

![](pone.0037581.t004){#pone-0037581-t004-4}

  Time point (weeks)     Control       HFCD          HFCSD      *P* [†](#nt108){ref-type="table-fn"}
  -------------------- ----------- ------------- ------------- --------------------------------------
  0                     56.8±11.1    68.4±20.6     56.4±12.9                     NS
  5                     54.0±5.0    318.8±141.7   283.8±49.5                   \<.01
  10                    39.2±7.5    339.2±146.5   259.2±107.5                  \<.01
  14                    21.8±5.6    212.0±138.4   152.3±43.3                   \<.05
  19                    22.8±6.3    236.4±102.7   248.2±78.6                   \<.001
  23                    20.8±9.4    220.6±102.2   186.8±46.7                   \<.001
  27                    20.6±5.8    201.4±85.2    193.4±86.2                   \<.01

Values are mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t005

###### Fasting plasma glucose levels (mg/dL).

![](pone.0037581.t005){#pone-0037581-t005-5}

  Time point (weeks)     Control        HFCD        HFCSD      *P* [†](#nt110){ref-type="table-fn"}
  -------------------- ------------ ------------ ------------ --------------------------------------
  0                     111.8±12.0   122.6±48.5   119.2±21.9                    NS
  5                     98.6±17.2    100.5±12.0   100.0±23.2                    NS
  10                    93.8±15.7    91.8±27.0    83.0±11.1                     NS
  14                    116.4±32.2   104.6±15.6   108.6±30.5                    NS
  19                    92.4±10.5    95.0±13.1    88.8±25.5                     NS
  23                    87.6±19.8     77.2±7.2    92.0±19.2                     NS
  27                     81.6±7.7    89.6±14.6    101.0±13.0                    NS

Values are mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t006

###### White blood cell count (10^2^/µL).

![](pone.0037581.t006){#pone-0037581-t006-6}

  Time point (weeks)     Control      HFCD        HFCSD      *P* [†](#nt112){ref-type="table-fn"}
  -------------------- ----------- ----------- ------------ --------------------------------------
  0                     45.8±11.4   61.8±17.1   65.0±16.3                     NS
  5                     68.6±15.5   85.7±14.6   90.0±19.9                     NS
  10                    67.6±12.5   70.8±23.0   78.4±11.1                     NS
  14                    69.4±5.2    87.2±25.9   85.2±13.3                     NS
  19                    68.0±14.8   69.6±12.4   83.4±13.7                     NS
  23                    86.0±21.6   90.2±32.0   100.6±26.1                    NS
  27                    61.8±15.2   75.8±18.6   62.6±34.4                     NS

Values are the mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t007

###### The ratio of basophils to white blood cells (%).

![](pone.0037581.t007){#pone-0037581-t007-7}

  Time point (weeks)    Control    HFCD      HFCSD    *P* [†](#nt114){ref-type="table-fn"}
  -------------------- --------- --------- --------- --------------------------------------
  0                     0.0±0.0   0.3±0.5   0.0±0.0                    NS
  5                     0.2±0.4   0.0±0.0   0.2±0.4                    NS
  10                    0.3±0.4   0.2±0.4   0.3±0.4                    NS
  14                    0.2±0.4   0.0±0.0   0.4±0.5                    NS
  19                    0.0±0.0   0.0±0.0   0.0±0.0                    NS
  23                    0.2±0.4   0.0±0.0   0.0±0.0                    NS
  27                    0.1±0.2   0.5±0.5   0.4±0.5                    NS

Values are the mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t008

###### The ratio of eosinophils to white blood cells (%).

![](pone.0037581.t008){#pone-0037581-t008-8}

  Time point (weeks)    Control    HFCD      HFCSD    *P* [†](#nt116){ref-type="table-fn"}
  -------------------- --------- --------- --------- --------------------------------------
  0                     2.8±2.6   2.8±1.5   2.0±2.2                    NS
  5                     3.6±1.9   3.0±1.0   3.0±1.4                    NS
  10                    3.1±1.4   3.2±1.3   4.1±1.7                    NS
  14                    3.0±1.9   3.3±1.3   2.4±1.7                    NS
  19                    5.0±2.7   4.1±0.7   5.6±1.8                    NS
  23                    4.6±1.7   6.2±2.7   4.4±0.9                    NS
  27                    2.8±0.8   3.1±1.9   3.4±1.1                    NS

Values are the mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t009

###### The ratio of neutrophils to white blood cells (%).

![](pone.0037581.t009){#pone-0037581-t009-9}

  Time point (weeks)     Control      HFCD        HFCSD     *P* [†](#nt118){ref-type="table-fn"}
  -------------------- ----------- ----------- ----------- --------------------------------------
  0                     52.8±16.0   59.6±1.8    54.0±15.5                    NS
  5                     53.8±9.8    55.0±1.0    60.2±3.8                     NS
  10                    43.1±10.3   41.2±6.3    45.5±2.6                     NS
  14                    44.8±7.4    53.0±11.9   51.4±6.1                     NS
  19                    52.2±7.0    48.1±5.4    44.8±4.1                     NS
  23                    56.2±9.2    51.6±3.0    50.6±9.9                     NS
  27                    58.8±13.8   60.1±4.4    48.0±18.5                    NS

Values are the mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t010

###### The ratio of lymphocytes to white blood cells (%).

![](pone.0037581.t010){#pone-0037581-t010-10}

  Time point (weeks)     Control      HFCD        HFCSD     *P* [†](#nt120){ref-type="table-fn"}
  -------------------- ----------- ----------- ----------- --------------------------------------
  0                     37.5±11.0   31.1±4.0    36.8±13.1                    NS
  5                     34.8±10.5   36.3±3.5    30.4±2.9                     NS
  10                    45.2±7.4    45.8±6.0    44.7±3.0                     NS
  14                    44.6±9.3    36.2±10.7   39.2±6.4                     NS
  19                    36.9±6.9    42.0±4.9    43.4±3.8                     NS
  23                    33.6±7.6    34.0±2.9    39.6±10.2                    NS
  27                    32.3±13.5   29.5±5.0    41.2±19,5                    NS

Values are the mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t011

###### The ratio of monocytes to white blood cells (%).

![](pone.0037581.t011){#pone-0037581-t011-11}

  Time point (weeks)    Control    HFCD      HFCSD    *P* [†](#nt122){ref-type="table-fn"}
  -------------------- --------- --------- --------- --------------------------------------
  0                     7.0±3.4   6.3±1.5   7.3±3.9                    NS
  5                     7.6±3.1   5.7±2.5   6.2±1.8                    NS
  10                    8.0±3.2   9.6±1.8   5.4±2.1                    NS
  14                    7.4±1.5   7.5±0.9   6.6±2.3                    NS
  19                    6.0±2.1   5.8±1.1   6.2±1.8                    NS
  23                    5.4±1.3   8.2±1.9   5.2±2.1                 N \<.05
  27                    6.0±1.9   6.8±1.0   7.0±1.2                    NS

Values are mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

10.1371/journal.pone.0037581.t012

###### Effect of diet on organ weight of miniature pigs (g).

![](pone.0037581.t012){#pone-0037581-t012-12}

  Organ       Control        HFCD        HFCSD      *P* [†](#nt124){ref-type="table-fn"}
  --------- ------------ ------------ ------------ --------------------------------------
  Heart      149.7±5.5    163.3±4.2    153.7±22.9                    NS
  Liver      328.0±33.2   667.7±80.9   682.3±21.6                  \<.001
  Kidney      86.3±7.5    99.0±12.5     97.7±4.9                     NS
  Stomach    169.3±15.2   181.7±13.8   180.0±26.5                    NS
  Spleen      36.3±3.1    72.0±12.2    74.7±13.3                   \<.01

Values are mean ± SD. NS; not significant.

*P* values were calculated using a one-way factorial ANOVA.

Microarray gene expression profiles -- Correlation of gene expression {#s2b}
---------------------------------------------------------------------

RNA analyses were conducted on blood samples obtained at weeks 10, 19, and 27 of the feeding periods to characterize the dietary effects on gene expression profiles in whole blood and white blood cells of miniature pigs. Each RNA sample was analyzed by aporcine gene expression microarray consisting of 43603 oligonucleotide probes.

We evaluated variation in correlation coefficients among individuals on the same diet and between different diet groups. Pearson correlation coefficients were used for the correlation analysis. Correlation coefficients for 45 microarrays in total were obtained for a normalized signals log-scale after excluding "absent" spots, definition of "absent" were described in [Materials and Methods](#s4){ref-type="sec"}. A color-coded pairwise correlation matrix is displayed in [Figure 2](#pone-0037581-g002){ref-type="fig"}.

![Correlation matrix of dietary-related gene expression profiles of whole blood and white blood cells.\
This color-coded correlation matrix illustrates pairwise correlations between the levels of gene expression in individuals. Probe sets with normalized signals (log-transformed and scaled) were used to calculate correlations between 45 arrays using Pearson correlation coefficient; signals flagged as "absent" were excluded. The color scale at the bottom indicates the strengths of the correlations.](pone.0037581.g002){#pone-0037581-g002}

[Figure 3](#pone-0037581-g003){ref-type="fig"} illustrates the mean correlation coefficients for gene expression profiles among individuals within the same dietary group, showed the individual difference of the gene expression profiles within the dietary groups during dietary period. [Figure 4](#pone-0037581-g004){ref-type="fig"} presents the mean correlation coefficients for gene expression profiles among different diet groups. The correlation coefficients of whole blood expression profiles within the same diet groups were 0.97 (0.01) (mean (standard deviation; SD)), 0.94 (0.05), and 0.97 (0.01) for the control, HFCD, and HFCSD whole blood at 10 weeks, 0.94 (0.03), 0.93 (0.06), and 0.95 (0.01) at 19 weeks, and 0.95 (0.02), 0.95 (0.03), and 0.98 (0.01) at 27 weeks, respectively. The correlation coefficients of white blood cell expression profiles within the same dietary groups were 0.94 (0.05), 0.95 (0.03), and 0.96 (0.02) for the control, HFCD, and HFCSD groups at 27 weeks, respectively. Using Fisher\'s Z-transformation to normalize the correlation distributions, no significant differences in correlation coefficients among dietary groups were observed at any period during the treatments. This indicates uniformity of dietary-induced hyperlipidemia for our protocols.

![Summary of dietary-related correlation coefficients within the same diet groups.\
(A) Whole blood after 10 weeks. (B) Whole blood after 19 weeks. (C) Whole blood after 27 weeks. (D) White blood cells after 27 weeks. The bottom and top of the boxes represent the 25th and 75th percentiles respectively. The lower and upper whiskers denote the minimum and maximum values of the data. Using Fisher\'s Z-transform for normalization the correlation distribution, continuous variables were analyzed by one-way factorial ANOVA followed by Tukey-Kramer multiple comparisons test for multiple groups. Correlations were considered to be statistically significant when ANOVA test among all groups and t-test between 2 groups should p\<0.05. NS; not significant.](pone.0037581.g003){#pone-0037581-g003}

![Summary of dietary-related correlation coefficients among different diet groups.\
(A) Whole blood after 10 weeks. (B) Whole blood after 19 weeks. (C) Whole blood after 27 weeks. (D) White blood cells after 27 weeks. The bottom and top of the boxes represent the 25th and 75th percentiles respectively. The lower and upper whiskers denote the minimum and maximum values of the data. Comparisons of the groups were made with the ANOVA test. NS; not significant.](pone.0037581.g004){#pone-0037581-g004}

Next, we analyzed expression profile correlations among the different diet groups. In [Figure 4](#pone-0037581-g004){ref-type="fig"}, "control vs. HFCD" represents the mean correlation coefficient between control and HFCD group individuals. The whole blood correlation coefficients among the different diet groups were 0.95 (0.04), 0.97 (0.01), and 0.96 (0.04) for control vs. HFCD, control vs. HFCSD, and HFCD vs. HFCSD at 10 weeks, 0.93 (0.03), 0.94 (0.02), and 0.95 (0.03) at 19 weeks, and 0.95 (0.03), 0.91 (0.03), and 0.95 (0.03) at 27 weeks, respectively. The white blood cell correlation coefficients among the different diet groups were 0.94 (0.04), 0.94 (0.03), and 0.96 (0.02) for control vs. HFCD, control vs. HFCSD, and HFCD vs. HFCSD at 27 weeks, respectively. Correlations of whole blood expression profiles were statistically significant according to an ANOVA test among all groups at 27 weeks, as a low correlation coefficient was obtained for the control vs. HFCSD groups. This indicates HFCSD differs much from control group and slightly from HFCD 27 weeks in whole blood gene expression profiles.

[Figure 5](#pone-0037581-g005){ref-type="fig"} displays the average correlation coefficients between whole blood and white blood cell expression profiles within the same dietary group. The correlation coefficients were 0.83 (0.04), 0.79 (0.07), and 0.74 (0.05) for control, HFCD, and HFCSD at 27 weeks, respectively. Significant differences were observed between the control and HFCSD groups according to an ANOVA analysis using Fisher\'s Z-transform (P\<0.01).

![Correlation coefficients between whole blood and white blood cells within the same diet groups.\
Correlation coefficients were calculated between whole blood and white blood cells within the same diet group at 27 weeks feeding period. The bottom and top of the boxes represent the 25th and 75th percentiles respectively. The lower and upper whiskers denote the minimum and maximum values of the data. Comparisons of the groups were made with the ANOVA test. NS; not significant.](pone.0037581.g005){#pone-0037581-g005}

Assigning known functions to gene expression - Gene ontology annotation {#s2c}
-----------------------------------------------------------------------

We identified up- and down-regulated genes and classified these according to function using information from the Gene Ontology (GO) Database to understand the observed differences in whole blood gene expression profiles for the different dietary groups. Top-ranked genes with fold changes in expression greater than 2.0 (p\<0.05; HFCD, [Table 13](#pone-0037581-t013){ref-type="table"}; HFSCD, [Table 14](#pone-0037581-t014){ref-type="table"}) and less than 0.5 (p\<0.05; HFCD, [Table 15](#pone-0037581-t015){ref-type="table"}; HFSCD, [Table 16](#pone-0037581-t016){ref-type="table"}) were selected at 10, 19, and 27 weeks. Genes TC440907, TC448587 (ABCA1), and TC438339 were ranked highest in HFCD and HFCSD during the dietary period. These genes were analyzed using the Database for Annotation, Visualization and Integrated Discovery (DAVID; [Table 17](#pone-0037581-t017){ref-type="table"}, HFCD; [Table 18](#pone-0037581-t018){ref-type="table"}, HFCSD). As a result, the GO categories of many genes up-regulated at the end of the 19-week dietary period in both HFCD and HFCSD groups were related to nucleotide binding (GO: 0000166, GO: GO: 0005524, 0005525, GO: 0017076, GO: 0019001, GO: 00032553, GO: 00032555, GO: 0032561). The GO categories of gene up-regulated after 19 weeks in the HFCD group only were related to catabolic processes (GO: 0009057, GO: 0019941, GO: 0030163, GO: 0043632, GO: 0044257, GO: 0044265,). Many genes down-regulated after 27 weeks in both HFCD and HFCSD groups were in the GO categories related to biological adhesion (GO: 0007155, GO: 0022610). In addition, many genes down-regulated at the end of the 27-week dietary period in the HFCSD group only were related to steroid metabolism and lipid biosynthesis (GO: 0006694, GO: 0008202, GO: 0008203, GO: 0008610, GO: 0016125, GO: 0016126).

10.1371/journal.pone.0037581.t013

###### Top 10 significantly up-regulated genes in HFCD.

![](pone.0037581.t013){#pone-0037581-t013-13}

  Whole blood at 10 weeks    Whole blood at 19 weeks   Whole blood at 27 weeks   White blood cells at 27 weeks                                                               
  ------------------------- ------------------------- ------------------------- ------------------------------- -------- ----- ---------- -------- ----- ----------- ------- -----
  TC440907                                                       5.8                       TC440907                       7.7   TC440907            8.5   TC410790    IRG6    5.9
  TC438339                                                       5.7                       TC506587                       6.2   TC487165   CXCL10   7.3   TC448587    ABCA1   5.3
  TC448587                            ABCA1                      5.3                       TC448587              ABCA1    4.8   TC441966    UPK2    5.9   TC440907            5.1
  TC414205                                                       3.8                       TC407415               MX2     4.7   TC410790    IRG6    5.5   TC447991            4.3
  TC407338                             MX1                       3.4                       Ssc.51683             ABCB4    4.3   TC448587   ABCA1    5.3   TC438339            4.0
  TC432467                                                       3.1                       TC426495                       4.3   TC438339            5.1   TC453638            4.0
  TC407865                                                       2.9                       TC438339                       4.0   TC490662   ROMO1    4.7   TC450749            3.5
  TC448870                                                       2.9                       TC450749                       3.9   TC506587            4.4   TC407748    PCD1B   3.4
  TC467477                          SERPING1                     2.7                       TC425970              LGALS9   3.8   TC427843            3.6   TC426495            3.3
  TC445197                                                       2.6                       TC450410                       3.8   TC453638            3.6   Ssc.48813           3.2

10.1371/journal.pone.0037581.t014

###### Top 10 significantly up-regulated genes in HFCSD.
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  Whole blood at 10 weeks    Whole blood at 19 weeks   Whole blood at 27 weeks   White blood cells at 27 weeks                                                                 
  ------------------------- ------------------------- ------------------------- ------------------------------- -------- ------ ----------- ------- ------ ----------- ------- ------
  TC448587                            ABCA1                      4.0                       TC487165              CXCL10   15.7   NP411727    GRK7    17.9   Ssc.9135            20.1
  TC438339                                                       4.0                       TC440907                       8.4    TC490662    ROMO1   16.9   TC434357            11.6
  TC440907                                                       3.8                       TC509090                       5.1    TC417023            15.6   TC511398            8.5
  TC411549                                                       3.1                       TC448587              ABCA1    5.0    TC480907            13.5   TC473927            7.1
  TC472367                                                       2.4                       TC450410                       4.9    TC444971            13.3   Ssc.24568           6.7
  TC433245                                                       2.1                       TC438339                       4.5    TC511837            12.7   TC448587    ABCA1   5.7
                                                                                           TC470851                       4.5    TC423285            12.2   TC438339            4.9
                                                                                           TC480583                       4.4    Ssc.46601           11.8   TC440907            4.8
                                                                                           TC410790               IRG6    4.3    Ssc.56049           11.5   TC430783            4.4
                                                                                           Ssc.5472                       4.1    Ssc.35808           11.2   TC512775            4.3

10.1371/journal.pone.0037581.t015

###### Top 10 significantly down-regulated genes in HFCD.
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  Whole blood at 10 weeks    Whole blood at 19 weeks   Whole blood at 27 weeks   White blood cells at 27 weeks                                                               
  ------------------------- ------------------------- ------------------------- ------------------------------- -------- ----- ----------- ------ ----- ----------- -------- -----
  TC431538                                                       0.2                       TC418697                       0.1   TC427825           0.2   TC415077             0.2
  TC409256                                                       0.2                       TC502826                       0.1   TC416132           0.2   TC417273             0.2
  TC437880                                                       0.2                       TC407798              WNT10B   0.2   TC463385           0.2   Ssc.25428            0.3
  Ssc.31818                                                      0.2                       TC433727                       0.2   Ssc.50105          0.3   Ssc.56656    SQLE    0.3
  TC434967                                                       0.3                       TC495620               IL18    0.2   Ssc.67286          0.3   TC436654             0.4
  TC423396                                                       0.3                       TC503806                       0.2   TC462549           0.3   TC491413             0.4
  TC440884                                                       0.3                       TC468870                       0.2   TC409660           0.3   TC407223    MYO7A    0.4
  TC443308                                                       0.3                       TC410474                       0.2   TC414897    CNN1   0.3   TC478649    PFKFB1   0.4
  Ssc.46725                                                      0.3                       TC466297               MGP     0.2   TC423618           0.3   TC473047             0.4
  Ssc.38146                                                      0.3                       TC449799                       0.2   TC494014           0.3   TC446195             0.4

10.1371/journal.pone.0037581.t016

###### Top 10 significantly down-regulated genes in HFCSD.

![](pone.0037581.t016){#pone-0037581-t016-16}

  Whole blood at 10 weeks    Whole blood at 19 weeks   Whole blood at 27 weeks   White blood cells at 27 weeks                                                               
  ------------------------- ------------------------- ------------------------- ------------------------------- -------- ----- ----------- -------- ----- ----------- ------ -----
  Ssc.56656                           SQLE                       0.3                       TC491388              CCL3L1   0.2   TC442299             0.2   TC491413           0.2
  TC426935                                                       0.4                       TC407798              WNT10B   0.2   TC407798    WNT10B   0.2   TC414897    CNN1   0.2
  Ssc.47297                                                      0.4                       TC486323                       0.3   Ssc.56656    SQLE    0.2   TC443738           0.2
  Ssc.58815                                                      0.4                       Ssc.36434                      0.3   TC471905             0.3   TC421743           0.2
  Ssc.32174                                                      0.4                       TC452410               MAOA    0.3   TC429709             0.3   TC412754           0.2
  TC452974                                                       0.4                       Ssc.56656              SQLE    0.3   TC472114             0.3   TC463385           0.3
  TC477452                                                       0.5                       TC413430                       0.3   TC423826             0.3   TC477521           0.3
  TC418062                                                       0.5                       TC410474                       0.3   TC458674             0.3   NP7655660          0.3
  TC491240                                                       0.5                       TC509046                       0.3   TC417970             0.3   TC442860    TPM1   0.3
  TC495442                                                       0.5                       Ssc.61167                      0.3   TC437991             0.3   TC417854           0.3

10.1371/journal.pone.0037581.t017

###### Functional classes of up- or down-regulated genes between HFCD and control.
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  Weeks    Induction/Repression   Category   Accession                               Term                               \%    P-value
  ------- ---------------------- ---------- ------------ ------------------------------------------------------------ ------ ---------
  10            Induction          GO MF     GO:0003924                        GTPase activity                         28.6   1.9e−02
  10            Induction           KEGG                             complement and coagulation cascades               28.6   2.2e−02
  19            Induction          GO MF     GO:0032555                 purine ribonucleotide binding                  13.6   3.9e−03
  19            Induction          GO MF     GO:0032553                     ribonucleotide binding                     13.6   3.9e−03
  19            Induction          GO MF     GO:0000166                       nucleotide binding                       15.3   4.0e−03
  19            Induction          GO MF     GO:0003924                        GTPase activity                         5.1    4.7e−03
  19            Induction          GO MF     GO:0017076                   purine nucleotide binding                    13.6   6.2e−03
  19            Induction          GO BP     GO:0019941        modification-dependent protein catabolic process        5.1    1.9e−02
  19            Induction          GO BP     GO:0043632     modification-dependent macromolecule catabolic process     5.1    1.9e−02
  19            Induction          GO BP     GO:0044257               cellular protein catabolic process               5.1    2.5e−02
  19            Induction          GO BP     GO:0051603   proteolysis involved in cellular protein catabolic process   5.1    2.5e−02
  19            Induction          GO MF     GO:0032561                 guanyl ribonucleotide binding                  6.8    2.6e−02
  19            Induction          GO MF     GO:0019001                   guanyl nucleotide binding                    6.8    2.6e−02
  19            Induction          GO MF     GO:0005525                          GTP binding                           6.8    2.6e−02
  19            Induction          GO BP     GO:0030163                   protein catabolic process                    5.1    2.7e−02
  19            Induction          GO BP     GO:0044265            cellular macromolecule catabolic process            5.1    3.5e−02
  19            Induction          GO BP     GO:0009057                macromolecule catabolic process                 5.1    4.9e−02
  27            Induction           KEGG                             Toll-like receptor signaling pathway              14.3   1.4e−02
  10            Repression         GO MF     GO:0004857                   enzyme inhibitor activity                    11.1   1.6e−02
  10            Repression         GO MF     GO:0004866                endopeptidase inhibitor activity                8.3    4.8e−02
  19            Repression         GO BP     GO:0002684          positive regulation of immune system process          7.9    1.3e−02
  27            Repression         GO BP     GO:0007155                         cell adhesion                          11.1   9.6e−03
  27            Repression         GO BP     GO:0022610                      biological adhesion                       11.1   9.6e−03
  27            Repression          KEGG                                     steroid biosynthesis                      5.6    4.0e−02

GO MF; GO molecular function, GO BP; GO biological process, Kegg; Kegg pathway.

10.1371/journal.pone.0037581.t018

###### Functional classes of up- or down-regulated genes between HFCSD and control.

![](pone.0037581.t018){#pone-0037581-t018-18}

  Weeks    Induction/Repression   Category   Accession                Term                 \%    P-Value
  ------- ---------------------- ---------- ------------ ------------------------------- ------ ---------
  19            Induction          GO MF     GO:0000166        nucleotide binding          13    3.7e−04
  19            Induction          GO MF     GO:0032555   purine ribonucleotide binding   9.8    5.1e−03
  19            Induction          GO MF     GO:0032553      ribonucleotide binding       9.8    5.1e−03
  19            Induction          GO MF     GO:0017076     purine nucleotide binding     9.8    8.2e−03
  19            Induction          GO MF     GO:0005524            ATP binding            6.5    4.8e−02
  27            Repression         GO BP     GO:0016125     sterol metabolic process      8.5    4.9e−04
  27            Repression          KEGG                      steroid biosynthesis        6.4    1.7e−03
  27            Repression         GO BP     GO:0008202     steroid metabolic process     8.5    2.3e−03
  27            Repression         GO BP     GO:0016126    sterol biosynthetic process    6.4    2.4e−03
  27            Repression          KEGG                    ECM-receptor interaction      8.5    4.0e−03
  27            Repression         GO BP     GO:0008203   cholesterol metabolic process   6.4    9.9e−03
  27            Repression         GO BP     GO:0006694   steroid biosynthetic process    6.4    1,1e−02
  27            Repression         GO BP     GO:0055114        oxidation reduction        12.8   1.5e−02
  27            Repression         GO BP     GO:0007155           cell adhesion           8.5    1.7e−02
  27            Repression         GO BP     GO:0022610        biological adhesion        8.5    1.7e−02
  27            Repression         GO BP     GO:0008610    lipid biosynthetic process     6.4    4.8e−02

GO MF; GO molecular function, GO BP; GO biological process, Kegg; Kegg pathway.

To investigate potential reasons for the differences in gene expression among the diet groups during the dietary period, Chi-square tests were performed to identify whole blood GO categories for each treatment group vs. the control group. The expected values represented the number of up- and down-regulated genes bearing all GO annotations at each period of the diet, and the observed values represented the number of up- and down-regulated genes bearing each specific GO term. A difference of p\<0.05 between groups was considered significant. To identify up- and down-regulated genes, we compared levels of expression for each gene between the control vs. HFCD groups and between the control vs. HFCSD groups at each period using Student\'s *t*-tests. As the lowest number of genes for which the expectation frequency reached 1 or higher was 140 according to the conditions of observed value, the GO terms, which involve more than 140 genes, were used for the Chi-square tests. The results of the Chi-square tests for up- and down-regulated genes are listed in [Tables 19](#pone-0037581-t019){ref-type="table"}--[](#pone-0037581-t020){ref-type="table"} [](#pone-0037581-t021){ref-type="table"} [22](#pone-0037581-t022){ref-type="table"}. The correlation coefficients of constituent gene between whole blood and white blood cells at 27 weeks were calculated for each GO term.

10.1371/journal.pone.0037581.t019

###### Predominant GO terms for which the ratio changed in HFCD and HFCSD.
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                                              Induction/Repressions   Correlation coefficients between whole blood and white blood cells at 27 weeks                          
  ------------ ----------------------- ----- ----------------------- -------------------------------------------------------------------------------- ----------- ----------- -----------
  GO:0006954    inflammatory response   155        Repression                                      Induction/Repression                                0.92±0.03   0.97±0.02   0.95±0.02
  GO:0000003        reproduction        310         Induction                                      Induction/Repression                                0.91±0.02   0.93±0.03   0.88±0.03

Values are mean ± SD.

10.1371/journal.pone.0037581.t020

###### Predominant GO terms for which the ratio changed in HFCD.
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                                                                        Correlation coefficients between whole blood and white blood cells at 27 weeks              
  ------------ -------------------------- ----- ---------------------- -------------------------------------------------------------------------------- ----------- -----------
  GO:0006936       muscle contraction      212   Induction/Repression                                     0.91±0.03                                      0.91±0.02   0.91±0.02
  GO:0007626      locomotory behavior      207   Induction/Repression                                     0.88±0.04                                      0.92±0.05   0.86±0.04
  GO:0007517    muscle organ development   199        Repression                                          0.94±0.05                                      0.95±0.02   0.94±0.02
  GO:0008152       metabolic process       145        Repression                                          0.93±0.02                                      0.92±0.05   0.96±0.03

Values are mean ± SD.

10.1371/journal.pone.0037581.t021

###### Predominant GO terms for which the ratio changed in HFCSD.
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                                                                                                     Correlation coefficients between whole blood and white blood cells at 27 weeks              
  ------------ ------------------------------------------------------- ----- ---------------------- -------------------------------------------------------------------------------- ----------- -----------
  GO:0006412                         Translation                        253   Induction/Repression                                     0.90±0.02                                      0.92±0.03   0.87±0.03
  GO:0009792    embryonic development ending in birth or egg hatching   432   Induction/Repression                                     0.92±0.02                                      0.93±0.03   0.90±0.02
  GO:0006118                     electron transport                     200   Induction/Repression                                     0.82±0.07                                      0.77±0.09   0.83±0.11
  GO:0006366        transcription from RNA polymerase II promoter       209   Induction/Repression                                     0.96±0.02                                      0.98±0.01   0.97±0.01
  GO:0040010             positive regulation of growth rate             207        Induction                                           0.92±0.02                                      0.92±0.04   0.86±0.04
  GO:0007166       cell surface receptor linked signaling pathway       185        Repression                                          0.97±0.01                                      0.93±0.06   0.97±0.01
  GO:0002119                 nematode larval development                374        Induction                                           0.91±0.02                                      0.93±0.03   0.88±0.03
  GO:0006886               intracellular protein transport              191        Induction                                           0.91±0.06                                      0.86±0.08   0.86±0.07
  GO:0001666                     response to hypoxia                    189        Repression                                          0.95±0.02                                      0.95±0.03   0.92±0.02
  GO:0040007                           Growth                           332        Induction                                           0.91±0.02                                      0.93±0.03   0.88±0.03

Values are mean ± SD.

10.1371/journal.pone.0037581.t022

###### Predominant GO terms for which the ratio unchanged in HFCD or HFCSD.
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                                                                                             Correlation coefficients between whole blood and white blood cells at 27 weeks              
  ------------ ---------------------------------------------------------------------- ----- -------------------------------------------------------------------------------- ----------- -----------
  GO:0007165                            signal transduction                            527                                     0.89±0.04                                      0.89±0.07   0.80±0.05
  GO:0008283                             cell proliferation                            353                                     0.91±0.03                                      0.87±0.07   0.83±0.05
  GO:0007267                            cell-cell signaling                            321                                     0.94±0.02                                      0.95±0.03   0.92±0.02
  GO:0008285                 negative regulation of cell proliferation                 288                                     0.95±0.03                                      0.87±0.08   0.83±0.06
  GO:0006468                     protein amino acid phosphorylation                    266                                     0.95±0.01                                      0.94±0.02   0.90±0.03
  GO:0008284                 positive regulation of cell proliferation                 262                                     0.92±0.04                                      0.96±0.02   0.90±0.03
  GO:0006916                               anti-apoptosis                              224                                     0.91±0.03                                      0.93±0.03   0.89±0.02
  GO:0042493                              response to drug                             218                                     0.93±0.03                                      0.93±0.05   0.85±0.04
  GO:0007399                         nervous system development                        210                                     0.82±0.06                                      0.82±0.08   0.74±0.04
  GO:0006508                                Proteolysis                                210                                     0.90±0.04                                      0.93±0.03   0.94±0.04
  GO:0006470                    protein amino acid dephosphorylation                   198                                     0.91±0.07                                      0.90±0.09   0.84±0.06
  GO:0000122    negative regulation of transcription from RNA polymerase II promoter   193                                     0.93±0.03                                      0.91±0.04   0.89±0.03
  GO:0015031                             protein transport                             190                                     0.95±0.03                                      0.96±0.02   0.94±0.03
  GO:0009887                            organ morphogenesis                            186                                     0.93±0.03                                      0.93±0.05   0.92±0.01
  GO:0006357        regulation of transcription from RNA polymerase II promoter        179                                     0.93±0.04                                      0.94±0.04   0.89±0.03
  GO:0001764                              neuron migration                             174                                     0.96±0.01                                      0.95±0.02   0.93±0.01
  GO:0007264                 small GTPase mediated signal transduction                 157                                     0.97±0.01                                      0.94±0.05   0.99±0.00
  GO:0007275                    multicellular organismal development                   151                                     0.95±0.03                                      0.93±0.04   0.91±0.02
  GO:0007420                             brain development                             150                                     0.89±0.10                                      0.89±0.09   0.88±0.09
  GO:0043066                      negative regulation of apoptosis                     145                                     0.94±0.04                                      0.95±0.02   0.93±0.01

Values are mean ± SD.

[Table 19](#pone-0037581-t019){ref-type="table"} lists the GO terms for which significant differences were observed in the HFCD and HFCSD groups relative to the expected values. Inflammatory response elements (GO:0006954) were repressed in the HFCD group, and were both induced and repressed in the HFCSD group. The correlation coefficients between whole blood and white blood cells for expression levels of inflammatory response genes were 0.92 (0.03), 0.97 (0.02), and 0.95 (0.02) for the control, HFCD, and HFCSD groups, respectively. Genes involved in reproduction (GO:0000003) were induced in the HFCD group, and were both induced and repressed in the HFCSD group. The correlation coefficients for expression levels of genes involved in reproduction between whole blood and white blood cells were 0.91 (0.02), 0.93 (0.03), and 0.88 (0.03) for the control, HFCD, and HFCSD groups, respectively.

[Table 20](#pone-0037581-t020){ref-type="table"} lists the GO terms for which significant differences were observed in the HFCD group compared to the expected values. Muscle contraction (GO:0006936) and locomotor behavior (GO:0007626) elements were both induced and repressed. Muscle organ development (GO:0007517) and metabolic processes (GO:0008152) were repressed.

[Table 21](#pone-0037581-t021){ref-type="table"} lists the GO terms for which significant differences were observed in the HFCSD group compared to the expected values. Translation (GO:0006412), embryonic development ending in birth or egg hatching (GO:0009792), electron transport (GO:0006118), and transcription from the RNA polymerase II promoter (GO:0006366) elements were both induced and repressed. Positive regulation of growth rates (GO:0040010), nematode larval development (GO:0002119), intracellular protein transport (GO:0006886) and growth (GO:0040007) elements were induced. A cell surface receptor-linked signaling pathway (GO:0007166) and responses to hypoxia (GO:0001666) were repressed.

[Table 22](#pone-0037581-t022){ref-type="table"} lists the GO terms for which ratios to the expected values were unchanged in the HFCD and HFCSD groups. In addition, the ratios of up- and down-regulated genes to the each observed values were unchanged at 27 weeks.

[Figure 6](#pone-0037581-g006){ref-type="fig"} depicts a scatter plot of correlation coefficients between whole blood and white blood cells for each GO term, selected for the Chi-square tests, at 27 weeks of each dietary treatment group relative to the control group. The slope of the HFCD to the controls regression line was 1.007 (p\<0.001). The slope of the HFCSD to the controls regression line was 1.097 (p\<0.001), indicating that the correlation coefficients between whole blood and white blood cell expression levels for many GO terms were low. The predominant GO terms with low correlation coefficients in the HFCSD group were nervous system development (GO:0007399), biological processes (GO:0008150), signal transduction (GO:0007165), regulation of transcription, DNA-dependent (GO:0006355), and cell proliferation (GO:0008283). In contrast, the predominant GO terms with high correlation coefficients in the HFCSD group were skeletal system development (GO:0001501), small GTPase mediated signal transduction (GO:0007264), synaptic transmission (GO:0007268), cell surface receptor linked signaling pathway (GO:0007166), and transcription from the RNA polymerase II promoter (GO:0006366).

![Scatter plot of dietary-related correlation coefficients.\
(A) Control vs. HFCD. (B) Control vs. HFCSD. The correlation coefficient between whole blood and white blood cells after 27 weeks of each GO tem was plotted for each spot. The solid line represents the regression line. The dashed line represents the slope equal to 1.](pone.0037581.g006){#pone-0037581-g006}

The intensity ratio of white blood cells to whole blood is a contribution indicator of the white blood cell RNA to whole blood gene expression. To focus on obesity-related organs, i.e., the liver, adipose tissue, and muscle, the relative numbers of ESTs for these organs to blood ESTs for each gene were calculated using EST profiles from the Unigene NCBI database of the transcriptome. The normalized EST values increase when the contribution indicator is small, as shown in [Figure 7](#pone-0037581-g007){ref-type="fig"}.

![The relation of tissue or organ ESTs to the white blood cell contribution indicator.\
The X-axis indicates the expression intensity ratio of white blood cells to whole blood for each gene as the white blood cell contribution indicator in our experiments. The Y-axis indicates the liver, adipose tissue, or muscle EST numbers normalized to the blood EST number of each gene in Unigene, an NCBI database of the transcriptome.](pone.0037581.g007){#pone-0037581-g007}

Discussion {#s3}
==========

This study aimed to evaluate the transition of gene expression profiles caused by dietary-induced hyperlipidemia through blood microarray analyses of miniature pigs during a 27-week dietary period.

Dietary-induced hyperlipidemia miniature pig models have previously been established. There are 2 main types of dietary protocol, one containing cholesterol and animal lipids [@pone.0037581-Kobari1]--[@pone.0037581-Bowles1], and the other containing cholesterol, animal lipids, and sucrose [@pone.0037581-Yin1], [@pone.0037581-Zhang1]. Some studies have focused their attention on certain kinds of candidate genes with specific functions, but this has not clarified a complete projection of whole blood RNA profiles of the transitions caused by diet-induced hyperlipidemia. Excessive exposure to dietary fats and/or sugars is an essential factor in the initiation of obesity and metabolic syndrome-associated pathologies, two typical conditions associated with diet-induced hyperlipidemia. The fasting plasma total cholesterol level increased within a month, and then, either remained high or decreased in the high-fat and high-cholesterol diet (HFCD) models [@pone.0037581-Kobari1], [@pone.0037581-DeKeyzer1], [@pone.0037581-Bowles1]. In contrast, fasting plasma total cholesterol levels increased throughout the dietary period in the high-fat, high-cholesterol, and high-sucrose diet (HFCSD) models [@pone.0037581-Zhang1]. Therefore, in the present study, hyperlipidemia was induced by the administration of a high-fat and high-cholesterol diet or a high-fat, high-cholesterol, and high sucrose diet to Clawn miniature swine.

Fasting plasma lipid values increased rapidly and were maintained at a high level during the 27-week feeding period under both feeding treatments. However, fasting plasma glucose concentrations remained unchanged. The liver and spleen weights increased significantly after the 27 weeks, and fatty livers were reported based on autopsies of individuals from both treatment groups. There was no significant difference in body weight, hematology, or other biochemical aspects of blood between individuals from the 2 dietary treatments.

Gene expression profiles of dietary-induced hyperlipidemia for whole blood RNA {#s3a}
------------------------------------------------------------------------------

We used whole blood to evaluate the transition of gene expression profiles. Whole blood RNA is easy to handle compared to isolated white blood cell RNA. In addition, whole blood contains a heterogeneous mixture of subpopulations of blood cells. Associated changes will be reflected on whole blood RNA once a great change has occurred in the composition and expressing condition of subpopulations, tissues, or organs. We previously evaluated the "healthy state" gene expression profile by whole blood microarray analyses of miniature pigs of different age groups, and identified characteristics of age-related gene expression by taking into account the change in the number of expressed genes by age and the similarities of gene expression intensity between individuals [@pone.0037581-Takahashi1]. The report on the healthy state of miniature pigs found that the correlation coefficients within the same age groups were 0.87 (0.04), 0.93 (0.03), 0.98 (0.01), and 0.96 (0.02), for the fetal stage, and for 12-, 20-, and 30-week-old male pigs, respectively. Variation in gene expression was greatest for younger subjects and diminished with age. These results indicate that uniformity of laboratory animals can be expected in miniature pigs after 20 weeks of age.

In this study, feeding treatments commenced when the pigs were 12 weeks old, RNA analysis was conducted on whole blood sampled after 10, 19, and 27 weeks of the feeding period, and on white blood cell RNA after 27 weeks. Variation in whole blood gene expression intensity among individuals within either the HFCD or the HFCSD group was in the same range as that of the controls at any period, indicating uniformity of dietary-induced hyperlipidemia expression profiles in miniature pigs.

Effects of white blood cells on whole blood gene expression profiles in dietary-induced hyperlipidemia {#s3b}
------------------------------------------------------------------------------------------------------

Most of the nucleated cells in blood are white blood cells such as neutrophils, T cells, B cells, and monocytes. Min et al. reported highly correlated results (r^2^ = 0.85) for 8,273 genes expressed in both whole blood RNA and peripheral blood mononuclear cell (PBMCs) RNA samples from healthy volunteers [@pone.0037581-Min1]. Other researchers have conducted a large-scale genome-wide expression analysis of white blood cell subpopulations [@pone.0037581-Cobb1]. That study indicated that correlation coefficients for T cells and monocytes among different healthy subjects were 0.98 (0.01) and 0.97 (0.01), respectively. However, the correlation coefficient between T cells and monocytes for the same subjects (n = 5) was 0.88 (0.01), indicating varied correlations between white blood cell subpopulations [@pone.0037581-Cobb1]. We believe that no effects of composition ratio of white blood cell subpopulations were observed in our study, because the ratios of granulocytes (neutrophils, eosinophils, and basophils), lymphocytes, and monocytes to white blood cells were statistically insignificant among the three test groups.

In previous studies, tumor-derived RNA was detected in the circulation of cancer patients [@pone.0037581-Kopreski1], [@pone.0037581-Lo1]. It has also been demonstrated that fetal RNA can be detected in maternal plasma [@pone.0037581-Poon1]. These results indicate that whole blood RNA may contain RNA originating from the tissues and/or organs. Hyperlipidemia is one of the risk factors associated with atherosclerosis. Atherosclerosis was induced by the administration of a high-fat and high-diet to Göttingen miniature swine for a 6-month period [@pone.0037581-Kobari1]. The liver and spleen weights were increased significantly compared to the controls in both the HFCD and HFCSC groups in our experiment at the end of each dietary period. Thus white blood cell microarray analyses were conducted at the end of each dietary period, as the tissues and/or organs, such as the liver, spleen, and blood vessels, were presumed to be influenced by dietary treatment.

The average white blood cell correlation coefficients within the HFCD and HFCSD groups were in the same range as that of the controls after the 27-week feeding period. However, variation in whole blood gene expression intensity between the HFCSD group and the control group was statistically significant, whilst variation in white blood cell gene expression intensity between the HFCSD group and the control group was not significant after the 27-week feeding treatments. In addition, the HFCSD correlation coefficient between whole blood and white blood cells after 27 weeks was significantly lower than that of the control and HFCD groups.

The intensity ratio of white blood cell gene expression to that of whole blood shows the contribution of white blood cell RNA to whole blood RNA samples. The intensity ratio of white blood cells to whole blood is, therefore, considered as the contribution indicator. We assume that the low intensity ratio of white blood cell to whole blood gene expression indicates a greater contribution of tissues and/or organs RNA to whole blood RNA. We then compared the EST numbers of the tissue or organ with the contribution indicator, focusing on obesity-related organs such as the liver, adipose tissue, and muscle. The number of gene ESTs for each tissue or organ normalized to blood ESTs becomes greater when the contribution indicator is small. As a result, we suggest that RNAs originating from tissues and/or organs are present in whole blood.

Characteristics of gene expression profiles in dietary-induced hyperlipidemia {#s3c}
-----------------------------------------------------------------------------

It is generally acknowledged that excessive exposure to dietary lipids disrupts the homeostasis of cellular metabolism and triggers an inflammatory response in adipose tissue [@pone.0037581-Hotamisligil1]. An enhanced inflammatory response has been observed in the livers of mice fed on high-fat diets and in skeletal muscles of Otsuka Long-Evans Tokushima Fatty (OLETF) rats using microarrays [@pone.0037581-Hayashi1]. We examined dietary-induced transitions of gene expression profiles for genes bearing GO terms. Major changes included an induction of proteins involved in catabolic processes and protein metabolism after a 19-week dietary period, especially in the HFCD group, and a reduced expression of proteins involved in steroid metabolism and lipid biosynthesis after a 27-week dietary period, especially in the HFCSD group.

In whole blood samples, some genes involved in inflammatory responses (GO: 0006954) were down-regulated in the HFCD group, whilst some genes involved in inflammatory responses were up-regulated and others were down-regulated in the HFCSD group.

It has been established that skeletal muscle is an obesity-related organ, such as the liver and adipose tissue, in association with insulin resistance [@pone.0037581-Hotamisligil1], [@pone.0037581-Roberts1], [@pone.0037581-Krotkiewski1]. Indeed, 2 out of 4 GO terms (muscle contraction, GO: 0006936, muscle organ development, GO: 0007517) that were statistically significant in the HFCD group were related to muscle function. Genes involved in reproduction (GO: 000003) were induced in the HFCD group, and were either induced or repressed in the HFCSD group. Asexual reproduction is the process by which an organism creates a genetically similar or identical copy of itself without the contribution of genetic material from another individual, and some genes involved in asexual reproduction are linked to the repair of damaged organs. Genes involved in translation (GO: 0006412), positive regulation of growth rate (GO: 0040010), and growth (GO: 004007) were induced in the HFCSD group, and these processes are also linked to organ repair. Meanwhile, GO terms that were statistically significant in the HFCSD group were mainly associated with cellular volatility, such as cellular activity, cell growth, or cellular responses.

We examined correlations between whole blood and white blood cells for genes bearing GO terms. The correlation coefficients for each GO term were calculated for the control, HFCD, and HFCSD groups after the 27-week feeding treatments. As a result, GO terms related to white blood cell function, including inflammatory responses (GO: 0006954), and cell surface receptor-linked signaling pathways (GO: 0007166) show high correlation coefficients in the control and dietary groups. In contrast, GO terms related to the repair of damaged organs, including translation (GO: 0006412), positive regulation of growth rate (GO: 0040010), and growth (GO: 004007), show low correlation coefficients in the HFCSC group.

The differences in the scatter plot regression slopes between the HFCD and control treatments and between the HFCSD and control treatments did not indicate a decrease in the extraction efficiency of RNA due to inhibitory substances in blood. In a previous study of microarray cDNA expression profiles using 23 healthy porcine tissue specimens, a large portion of the genes exhibited tissue-specific expression in agreement with mappings to gene descriptions [@pone.0037581-Hornshj1]. In our study, the minimum correlation coefficient for each GO term was 0.737 (0.038), while the maximum was 0.989 (0.004), indicating different values related to functions. The reason for the lower correlation may be due to the differences in gene expression between blood cells and organs, and because a stronger tendency for a decrease in correlation strength was observed in the HFCSD group as compared to the HFCD group. Our EST profile analysis also supported this assumption.

Statistically significant differences in fasting plasma lipids and glucose levels between the HFCD and HFCSD groups were not observed. However, blood RNA analyses demonstrated differences in the characteristics of dietary components between these groups. By considering variation in the dietary-induced hyperlipidemia gene expression profiles of miniature pigs, we have established that whole blood RNA analyses can be used in practical applications. The blood RNA diagnostics under development may eventually be useful for monitoring human health.

Materials and Methods {#s4}
=====================

Animals {#s4a}
-------

Fifteen 12-week-old, male Clawn miniature pigs were housed individually in cages of 1.5 m^2^ at the breeder\'s specific pathogen-free (SPF) facility (Japan Farm Co., Ltd, Kagoshima, Japan) for 27 weeks. Body weights at the beginning of the experiment were 5.1 (2.6) kg (mean (standard deviation; SD)). During this period, 5 pigs were fed with 450 g/day standard dry feed (Kodakara73, Marubeni Nisshin Feed Co., Ltd., Tokyo Japan), and had unlimited access to water (control group). Five pigs were fed a high-fat, high-cholesterol diet containing 15% lard and 2% cholesterol (HFCD group). The 5 remaining pigs were fed a high-fat, high-cholesterol and high-sucrose diet containing 15% lard, 2% cholesterol, and 37% sucrose (HFCSD group). During dissections, the heart, liver, kidney, stomach, and spleen were excised and weighed immediately.

Hematology and clinical chemistries {#s4b}
-----------------------------------

Blood samples were collected from the superior vena cava after 5, 10, 14, 19, 23, and 27 weeks of the feeding period. Blood (EDTA), plasma (EDTA), and serum samples for hematology and biochemical tests were collected 24 hours after fasting. Hematology and biochemical tests were conducted by Clinical Pathology Laboratory, Inc. (<http://www.patho.co.jp/index.html>) (Kagoshima, Japan) using standard clinical methods.

MIAME compliance and data availability {#s4c}
--------------------------------------

The microarray experiments described in this manuscript were MIAME compliant and the raw data have been deposited in the Gene Expression Omnibus (GEO) database (Accession number GSE 32616, <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32616>.

Preparation of samples and microarray assays {#s4d}
--------------------------------------------

Whole blood samples for microarray analyses were collected from each subject in PAXgene™ tubes (Qiagen/BD GmbH, UK), incubated at room temperature for 4 hours for RNA stabilization, and then stored at −80°C. RNA was extracted from whole blood using the PAXgene™ Blood RNA System Kit (Qiagen GmbH, Germany) according to the manufacturer\'s guidelines. RNA from white blood cells was extracted from whole blood samples using a LeukoLOCK Total RNA Isolation kit (Ambion, Austin, TX). Isolations were performed according to the manufacturer\'s protocol. The quality of the purified RNA was verified using an Agilent® 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). RNA concentrations were determined using a NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). Fluorescent cyanine 3-CTP--labeled cRNA was used for hybridization onto porcine oligo microarray slides (\#G2519F\#20109, Agilent Technologies) containing 43,603 oligonucleotide probes at 65°C for 17 h. The hybridized microarray slides were washed according to the manufacturer\'s instructions and were scanned with an Agilent DNA Microarray Scanner (\#G2565BA, Agilent Technologies) at 5-µm resolution. The scanned images were analyzed numerically using Agilent Feature Extraction Software version 9.5.3.1. (Agilent Technologies).

Microarray data analysis {#s4e}
------------------------

Normalized data using quantile normalization were analyzed using GeneSpring GX software version 10.0.1 (Agilent Technologies). The Gene Ontology (GO) Database (<http://www.geneontology.org/>) was used to categorize gene expression profiles functionally. GO terms were obtained from the TIGR pig gene indices, Porcine version 14.0 3-11-10 (<http://compbio.dfci.harvard.edu/cgi-bin/tgi/gimain.pl?gudb=pig>). The TC Annotator List includes the gene number and the GO terms. Out of the 43,603 probes used in the Agilent porcine microarray (\#G2519F\#20109), GO annotations were available for 6,019 genes. Microarray cDNA probes were classified according to GO terms for different biological processes.

For the microarray data analyses, we focused particularly on the variation of dietary-related gene expression profiles. Initially, microarray spots of interest were divided into 2 groups: "absent" and "present," using the flag values provided by the scanner. Background levels were determined from the spots outside of the gene probing area. "Absent" was assigned to spots with a signal intensity that was less than that of the background level, while the rest were marked "present." Only data for "present" spots were used for the analyses.

The intensity ratio of white blood cell gene expression to that of whole blood is a contribution indicator for white blood cell RNA to whole blood RNA. The relation of tissues or organs ESTs to the white blood cell contribution indicator was examined. To focus on obesity-related organs, i.e., the liver, adipose tissue, and muscle, the relative EST numbers of these organs to blood ESTs for each gene were calculated using EST profiles from the Unigene NCBI database of the transcriptome. An EST profile breakdown of 22,000 porcine genes by body site is available, comprising 40 organ types, such as the lung, ovary, liver, adipose tissue, muscle, and blood. The profiles show gene expression patterns inferred from EST counts and cDNA library sources (<http://www.ncbi.nlm.nih.gov/UniGene/>).

Statistical analysis {#s4f}
--------------------

Continuous variables were analyzed using a 1-way factorial ANOVA followed by a Tukey-Kramer multiple comparisons test for multiple groups. After excluding the unexpressed genes from each set of array data, Pearson correlation coefficients were calculated to identify similarities in gene expression among individuals. Pearson correlation coefficients were analyzed by a 1-way factorial ANOVA using Fisher\'s Z-transform to normalize the correlation distribution.

Correlations were considered statistically significant for ANOVA tests among all groups and *t*-tests between 2 groups when p\<0.05. All values were expressed as non-transformed mean (standard deviation (SD)). Genes with a fold change greater than 2.0 (p\<0.05) and less than 0.5 (p\<0.05) after 10, 19, and 27 weeks were identified. These genes were mapped to the Gene Ontology and KEGG pathway in the Database for Annotation, Visualization and Integrated Discovery (DAVID Bioinformatics Resources 6.7, National Institute of Allergy and Infectious Diseases, <http://david.abcc.ncifcrf.gov/>) [@pone.0037581-Huangda1], [@pone.0037581-Dennis1]. Chi-square tests were performed for feature extractions of GO terms. The expected values were the number of up- and down-regulated genes bearing all GO annotations, and the observed values were specific to each GO term. Simple linear regressions were performed for the scatter plots to obtain the slopes and intercepts, and the significance of each regression slope was verified.

Ethical considerations {#s4g}
----------------------

All experimental protocols were approved by the Committee for the Care and Use of Experimental Animals at AIST (Permit Number: 2009-055A).
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